COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series

被引：49
|
作者：
Hughes, Richard [1 ]
Pedotti, Rosetta [1 ]
Koendgen, Harold [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 42卷
关键词：
D O I：
10.1016/j.msard.2020.102192
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] COVID-19 in persons with multiple sclerosis treated with ocrelizumab: pharmacovigilance update
    Hughes, R.
    Fitovski, K.
    Whitley, L.
    Jessop, N.
    Schneble, H-M
    Muros-Le Rouzic, E.
    Sauter, A.
    Pedotti, R.
    Koendgen, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 49 - 49
  • [2] Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series
    De Mercanti, Stefania F.
    Vercellino, Marco
    Bosa, Chiara
    Alteno, Anastasia
    Schillaci, Valentina
    Clerico, Marinella
    Cavalla, Paola
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [3] COVID-19 in people with multiple sclerosis treated with ocrelizumab
    Hauser, S. L.
    Gold, R.
    Cutter, G.
    Fitovski, K.
    Schneble, H. -M.
    Whitley, L.
    Jessop, N.
    Sauter, A.
    Wang, Q.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 762 - 762
  • [4] COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
    Buttari, Fabio
    Bruno, Antonio
    Dolcetti, Ettore
    Azzolini, Federica
    Bellantonio, Paolo
    Centonze, Diego
    Fantozzi, Roberta
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [5] COVID-19 in ocrelizumab-treated people with multiple sclerosis
    Hughes, Richard
    Whitley, Louise
    Fitovski, Kocho
    Schneble, Hans-Martin
    Muros, Erwan
    Sauter, Annette
    Craveiro, Licinio
    Dillon, Paul
    Bonati, Ulrike
    Jessop, Nikki
    Pedotti, Rosetta
    Koendgen, Harold
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [6] Case report of relapsing COVID-19 infection in a patient with multiple sclerosis treated with ocrelizumab
    Pazderkova, J.
    Bartos, H.
    Dlouhy, P.
    Vachova, M.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (01) : 92 - 94
  • [7] Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
    Suwanwongse, Kulachanya
    Shabarek, Nehad
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [8] Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab
    Habek, Mario
    Piskac, Dominik
    Gabelic, Tereza
    Barun, Barbara
    Adamec, Ivan
    Skoric, Magdalena Krbot
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
  • [9] Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic
    Baba, Cavid
    Yigit, Pinar
    Dastan, Seda
    Hancer, Pelin
    Sagici, Ozge
    Ozakbas, Serkan
    Abasiyanik, Zuhal
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (01): : 3 - 8
  • [10] Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab
    Pedotti, Rosetta
    Muros-Le Rouzic, Erwan
    Raposo, Catarina
    Schippling, Sven
    Jessop, Nikki
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
12345